Earnings
ACST
0.2070
+3.24%
0.0065
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-03-31
14.24M
0.00
--
546.00K
--
--
0.00
--
--
--
977.00K
316.00K
16.08M
2.06M
--
0.00
--
--
4.24M
--
473.00K
6.77M
22.85M
--
1.71M
0.00
--
--
--
4.25M
--
76.00K
--
--
--
1.36M
7.39M
0.00
--
--
--
2.46M
2.46M
9.86M
137.42M
9.80M
-126.34M
--
--
--
12.99M
12.99M
22.85M
FY 2019-03-31
16.92M
8.92M
--
1.19M
--
--
0.00
--
--
--
837.92K
183.37K
28.05M
2.11M
--
20.29K
--
--
5.82M
--
418.59K
8.37M
36.43M
--
--
1.37M
--
--
--
12.35M
--
--
--
--
--
--
13.71M
0.00
--
--
--
12.22M
12.22M
25.93M
97.18M
6.22M
-93.14M
--
--
--
10.49M
10.49M
36.43M
FY 2019-03-31
16.87M
8.89M
--
1.19M
--
--
0.00
--
--
--
835.00K
183.00K
27.97M
2.11M
--
20.00K
--
--
6.39M
--
417.00K
8.93M
36.90M
--
3.05M
0.00
--
--
--
7.70M
--
0.00
--
--
--
1.56M
13.67M
0.00
--
--
--
12.18M
12.18M
25.85M
110.86M
8.15M
-100.83M
--
--
--
11.04M
11.04M
36.90M
FY 2018-03-31
6.38M
--
--
588.53K
--
--
0.00
--
--
--
314.81K
80.64K
7.36M
2.19M
--
20.16K
--
--
7.80M
--
430.35K
10.44M
17.80M
--
--
0.00
--
--
--
5.19M
--
--
--
--
--
--
5.19M
1.25M
--
--
--
4.98M
6.23M
11.43M
56.87M
5.39M
-56.12M
--
--
--
6.38M
6.38M
17.80M
FY 2018-03-31
6.22M
--
--
574.13K
--
--
0.00
--
--
--
307.11K
78.67K
7.18M
2.13M
--
19.67K
--
--
7.61M
--
419.82K
10.19M
17.37M
--
--
0.00
--
--
--
5.07M
--
--
--
--
--
--
5.07M
1.22M
--
--
--
4.86M
6.08M
11.15M
55.48M
5.26M
-54.75M
--
--
--
6.22M
6.22M
17.37M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ACST latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Acasti Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.